澳弘电子公告称，公司第三届董事会第八次会议审议通过向不特定对象发行可转换公司债券相关议案。 本次拟发行可转债募集资金5.8亿元，发行数量58万手，每张面值100元，期限6年，自2025年12月11日 至2031年12月10日，票面利率逐年递增。该可转债向原股东优先配售，原股东优先配售后余额网上发 售。此外，董事会同意发行完成后申请可转债在上海证券交易所上市，拟开设募集资金专项账户并签订 监管协议。 ...

Group 1 - Changhong Meiling's wholly-owned subsidiary, Changhong Air Conditioning, plans to invest 12.5784 million yuan in a technology transformation project to enhance production efficiency and reduce manufacturing costs [1] - Rongda Poultry's controlling shareholder, Liu Jiarong, has released a pledge on 18.7 million shares, which were previously pledged to China Everbright Bank [2] - Huitong Holdings intends to repurchase company shares worth between 30 million and 50 million yuan for equity incentives or employee stock ownership plans, with a maximum repurchase price of 40 yuan per share [3] Group 2 - Zhongding Co., Ltd. plans to issue convertible bonds to raise no more than 2.5 billion yuan for projects related to smart robots and to supplement working capital [4] - Zhibang Home intends to repurchase shares worth between 80 million and 110 million yuan for equity incentives or conversion of issued convertible bonds, with a maximum repurchase price of 14.13 yuan per share [5] Group 3 - ST Lifang's stock has experienced abnormal trading fluctuations, with a cumulative price deviation of -33.88% over two consecutive trading days, and the company is under investigation for false financial reporting [6] - Hefei Gaoke's shareholder, Xiong Qun, has reduced holdings by approximately 500,000 shares, amounting to about 9.47 million yuan [7] - Tongling Nonferrous Metals has received approval for its capital increase in the Tongling Nonferrous Metals Group Financial Company, raising its registered capital to 2 billion yuan [8]

Core Points - The Shenzhen Stock Exchange's Listing Review Committee approved Jiangxi Naipu Mining Machinery Co., Ltd.'s issuance of convertible bonds, confirming compliance with issuance and listing conditions as well as information disclosure requirements [1] Group 1: Issuance Details - The company plans to raise a total of up to 450 million yuan through the issuance of convertible bonds, with net proceeds intended for a new materials manufacturing project in Peru and to supplement working capital [3][5] - The total investment for the Peru project is estimated at 571.44 million yuan, with 325 million yuan allocated from the current fundraising [5] - The bonds will be convertible into the company's A-shares and are expected to be listed on the Shenzhen Stock Exchange's Growth Enterprise Market [5][6] Group 2: Financial Ratings and Management - The credit rating for the convertible bonds is A+, with a stable outlook for the company's overall credit rating also at A+ [7] - The underwriting and management of the bond issuance will be handled by Guojin Securities Co., Ltd., which has signed a management agreement with the company [6][8] Group 3: Previous Fundraising Activities - The company previously raised 400 million yuan through a convertible bond issuance in 2021, with net proceeds of approximately 392.7 million yuan after deducting issuance costs [9]

Group 1 - Meilixin plans to raise no more than 1.2 billion yuan for semiconductor equipment precision components, communication and automotive parts projects, and to supplement working capital [2] - Olin Bio has prepaid corporate income tax totaling 4.2001 million yuan, with no penalties from tax authorities [3] - Haisen Pharmaceutical's directors and executives plan to reduce their holdings by no more than 124,300 shares, accounting for 0.0816% of the total share capital [4] Group 2 - Aibulu intends to sell 47.4% and 31.6% stakes in its subsidiary Jinque Agriculture for a total of 12.3914 million yuan [5] - Chaoying Electronics plans to increase its Thai subsidiary's capital by 100 million USD for AI high-end PCB expansion [6] - Bona Film Group states that the box office revenue for "Avatar 3" is difficult to predict and the investment return rights are low [7] Group 3 - Junya Technology's PCB products for humanoid robots contribute less than 0.05% to its revenue [9] - Aerospace Electromechanical confirms that its main business does not involve commercial aerospace [10] - Deyi Culture's major shareholder plans to reduce holdings by no more than 2% of shares [11] Group 4 - China National Materials International signed a 2.7 billion yuan engineering contract for a molybdenum mining project [12] - Weiguang Bio plans to sign a 1.13 billion yuan technology cooperation contract for blood products [13] - Suhao Huihong intends to swap assets with its controlling shareholder for a 2.33% stake in Zijin Property Insurance [14] Group 5 - Haike Xinyuan's employee strategic placement plan intends to reduce holdings by no more than 2.5% of shares [15][16] - Taihao Technology's vice president resigns for personal reasons [17] - Huazhu Gaoke plans to establish a joint venture for 3D printing services with a total investment of 100 million yuan [18] Group 6 - Hubei Energy's November power generation was 2.617 billion kWh, a decrease of 17.94% year-on-year [19] - Dong'a Ejiao plans to repurchase shares worth 100 million to 200 million yuan for capital reduction [20] - Longjiang Transportation's shareholder reduced holdings by 1.2% [21] Group 7 - Feilu Co. plans to reduce holdings by no more than 1.02% of shares [22] - Zhongwei Electronics is planning a change in control, leading to a temporary stock suspension [23] - Zhongheng Group's subsidiary received approval for clinical trials of a new cancer drug [24] Group 8 - Guanzhong Ecology's controlling shareholder changed to Deep Blue Financial Whale [25] - Shennong Seed Industry is transferring a 3.8% stake in a subsidiary for 31.9827 million yuan [26] - Sun Cable's major shareholder plans to reduce holdings by no more than 3% of shares [27] Group 9 - Aiwei Electronics' application for issuing convertible bonds has been approved by the Shanghai Stock Exchange [28] - Chongqing Water intends to acquire wastewater treatment projects for 255 million yuan [29] - Boyun New Materials plans to increase its subsidiary's capital by 285 million yuan through debt-to-equity conversion [30] Group 10 - Zhongbai Group is closing unprofitable stores, expecting a loss of approximately 180 million yuan [31] - Changyuan Power's November power generation decreased by 17.88% year-on-year [32]

点击查看公告原文>> 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 责任编辑：小浪快报 登录新浪财经APP 搜索【信披】查看更多考评等级 通合科技（300491）12月3日发布公告称，公司已完成对深圳证券交易所（以下简称"深交所"）可转债 审核问询函的回复工作，并同步更新了募集说明书等申请文件的财务数据至2025年前三季度。公司表 示，本次向不特定对象发行可转换公司债券事项仍需履行深交所审核及中国证监会注册程序，最终能否 实施存在不确定性。 公告显示，公司于2025年11月13日收到深交所出具的《关于石家庄通合电子科技股份有限公司申请向不 特定对象发行可转换公司债券的审核问询函》（审核函〔2025〕020067号）。收到问询函后，公司会同 相关 ...

Core Viewpoint - Tonghe Technology has responded to the Shenzhen Stock Exchange's inquiry regarding performance fluctuations, gross margin changes, and cash flow status, while also disclosing financial data for the first three quarters of 2025, showing a revenue increase but a decline in net profit compared to the previous year [1] Group 1: Performance Analysis - In 2023, Tonghe Technology experienced significant revenue growth, but net profit has declined in 2024 due to intensified competition in the new energy power conversion business, which accounts for over 60% of revenue [2] - The revenue for the new energy power conversion business in the first three quarters of 2025 reached 645 million yuan, a year-on-year increase of 25.34%, but the gross margin fell to 17.80%, a decrease of 4.58 percentage points [2] - The company has implemented measures to address performance pressures, including expanding overseas markets and optimizing production capacity [2] Group 2: Financial Health - As of June 30, 2025, accounts receivable stood at 828 million yuan, a 68.85% increase from the end of 2022, while inventory value rose by 64.36% to 370 million yuan [3] - The current ratio and quick ratio have shown a downward trend, with values of 1.59 and 1.23 respectively as of September 30, 2025, and the debt-to-asset ratio increased by 13.63 percentage points to 48.64% [3] - The company has 174 million yuan in cash and cash equivalents available for debt repayment, indicating sufficient debt servicing capability [3] Group 3: Fundraising and Investment Projects - The proposed convertible bond aims to raise 522 million yuan for the development of power supply systems for data centers and to supplement working capital [4] - The company anticipates an annual production capacity of 6,240 complete sets and 57,000 modules for HVDC products, with expected gross margins of 30.97% and 37.89% respectively upon full production [4] - The company is optimistic about the market demand for data center power supplies, expecting to effectively absorb the new production capacity due to strong market conditions [4]

中国经济网北京12月3日讯佐力药业（300181）(300181.SZ)昨晚披露的向不特定对象发行可转换公司债 券预案显示，公司本次向不特定对象发行可转换公司债券募集资金总额不超过155,612.03万元(含本 数)，扣除发行费用后的募集资金净额拟用于以下项目：智能化中药大健康工厂(一期)、"乌灵+X"产品 研发项目和补充流动资金。 本次发行证券的种类为可转换为公司股票的可转换公司债券。该可转债及未来转换的股票将在深圳证券 交易所创业板上市。 本次发行的可转债每张面值为人民币100元，按面值发行。本次发行的可转债的期限为自发行之日起6 年。 本次发行的可转债采用每年付息一次的付息方式，到期归还所有未转股的可转债本金并支付最后一年利 息。 本次发行的可转债转股期自可转债发行结束之日起满6个月后的第一个交易日起至可转债到期日止(如遇 法定节假日或休息日延至其后的第一个工作日；顺延期间付息款项不另计息)。可转债持有人对转股或 者不转股有选择权，并于转股的次日成为公司股东。 本次可转债的发行对象为持有中国证券登记结算有限责任公司深圳分公司证券账户的自然人、法人、证 券投资基金、符合法律规定的其他投资者等(国家法律、法 ...

Core Viewpoint - Zhonglun New Materials Co., Ltd. is responding to the Shenzhen Stock Exchange's inquiry regarding its application for issuing convertible bonds, citing performance decline primarily due to fluctuations in crude oil prices and intensified industry competition [2][3]. Financial Performance - The company reported a slight increase in revenue but a continuous decline in net profit from 2022 to 2025, with revenues of 2.297 billion, 2.352 billion, 2.473 billion, and 1.537 billion yuan, and net profits of 285 million, 206 million, 113 million, and 67 million yuan respectively [2]. - The decline in performance is attributed to the correlation between raw material costs, particularly caprolactam, and crude oil prices, which dropped from $117.5 per barrel to $64.01 per barrel, a decrease of 45.53% [2]. Cash Flow and Debt Servicing - The company's operating cash flow turned positive by the end of September 2025, reaching 29.29 million yuan after being negative at -142 million yuan in the first half of 2025 [3]. - The company has sufficient debt servicing capability, with a coverage ratio of 183.13% based on the average operating cash flow over the past three years [3]. Profitability and Revenue Verification - There is a significant difference in gross margins between domestic and overseas sales, with domestic gross margin at 9.87% and overseas at 18.56% for the first nine months of 2025 [4]. - The company’s overseas revenue accounted for 54.22% of total revenue, with verification confirming the authenticity of overseas sales through various audit procedures [4]. Accounts Receivable and Inventory Management - As of the end of 2024, the company had accounts receivable of 234 million yuan, with a turnover rate of 7.23 times per year, indicating effective credit policies [5]. - Inventory management is also robust, with 96.13% of inventory aged less than one year and a low provision for inventory impairment at 1.23% [5]. Fundraising Projects - The company plans to use 868 million yuan from the convertible bond issuance for the industrialization project of high-performance membrane materials in Indonesia, which is expected to add 90,000 tons per year of BOPA membrane capacity [6][7]. - The project is anticipated to generate an additional net profit of 170 million yuan annually, with a gross margin of 17.74% [7].

格隆汇12月2日丨佐力药业(300181.SZ)公布，拟向不特定对象发行可转换公司债券募集资金总额不超过 155,612.03万元，扣除发行费用后的募集资金净额用于智能化中药大健康工厂（一期）、"乌灵+X"产品 研发项目、补充流动资金。 ...

智通财经APP讯，佐力药业(300181.SZ)发布向不特定对象发行可转换公司债券预案，本次向不特定对象 发行可转换公司债券募集资金总额不超过15.56亿元(含本数)，扣除发行费用后的募集资金净额拟用于以 下项目：智能化中药大健康工厂(一期)、"乌灵+X"产品研发项目以及补充流动资金。 ...